Stockscreener 앱 받기
1.04
10.34%
-0.12
전일 마감가:
$1.16
열려 있는:
$1.16
하루 거래량:
258.48K
시가총액:
$149.42M
수익:
-
순이익/손실:
$-41.23M
주가수익비율:
-1.4648
EPS:
-0.71
순현금흐름:
$-11.54M
1주 성능:
-30.20%
1개월 성능:
-55.93%
6개월 성능:
-65.68%
1년 성능:
+0.00%
1일 변동 폭
$1.01
$1.1694
52주 변동 폭
$1.01
$5.25
Renovaro Biosciences Inc Stock (RENB) Company Profile
명칭
Renovaro Biosciences Inc
전화
305 918 1980
주소
Century City Medical Plaza, Suite 906 2080 Century Park East, Los Angeles
Renovaro Biosciences Inc 주식(RENB)의 최신 뉴스
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
GlobeNewswire Inc.
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care
GlobeNewswire Inc.
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
GlobeNewswire Inc.
Statement of Renovaro Inc
GlobeNewswire Inc.
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Renovaro Biosciences Inc (RENB) 재무 분석
Renovaro Biosciences Inc (RENB) 순이익 2024
RENB은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -41.23M 달러로 보고했으며, 전년대비 +62.03% 증가했습니다.
Renovaro Biosciences Inc (RENB) 현금흐름 2024
2023-12-31 종료 분기에 RENB은 현금흐름(지난 12개월)으로 -11.54M 달러를 기록했으며, 전년 대비 +4.34% 증가했습니다.
Renovaro Biosciences Inc (RENB) 주당 순이익 2024
RENB이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -0.70달러이며, 전년 대비 +66.02% 성장했습니다.
1.06%
1.27%
자본화:
|
볼륨(24시간):